This site is intended only for healthcare professionals resident in the Republic of Ireland

Search

Menu

Close

Sign in or RegisterLog out
Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up
Menü
Schließen
Maternal ImmunisationMaternalMaternal Immunisation HomepageSafety ProfileDosingOlder AdultsOlder AdultsOlder Adults HomepageSafety ProfileDosingUseful ResourcesUseful ResourcesVideosMaterialsPreparationPrescribing Information

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Refer to section 4.8 of the SmPC for how to report adverse reactions.
Please refer to the ABRYSVO Summary of Product Characteristics for 
full prescribing information 

Vaccinating older adults with ABRYSVO can help protect against RSV disease.1


ABRYSVO
 is a vaccine indicated for the active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV).1

The use of this vaccine should be in accordance with official recommendations.1



RSV can have serious consequences for older adults.2

Many LRTD-related GP visits, hospitalisations, and deaths are attributable to RSV in older adults.3
 

175,000
GP visits


Example

14,000
hospital admissions


Almost 
8,000 deaths


Learn more about RSV & ABRYSVO with 5-minute eModules eModule 1: Understand RSV disease and the at-risk populations Loading eModule 2: What is ABRYSVO?
Dosing

 

Understand more about the dosing, administration and storage of ABRYSVO for older adults.
Learn moreLoading

Safety Profile

 

Learn more about the safety information of ABRYSVO in older adults.
Learn moreLoading

Useful Resources

 

Explore the ABRYSVO resources section for useful videos and materials.
VideosLoading Materials

LRTD =  Lower respiratory tract disease,  RSV = respiratory syncytial virus

 

References:

  1. ABRYSVO Summary of Product Characteristics.
  2. Centres for Disease Control and Prevention (CDC). RSV in Older Adults and Adults with Chronic Medical Conditions. Available at: https://www.cdc.gov/rsv/older-adults/ Accessed September 2024.
  3. Fleming et al. Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis 2015. 15:443.

Legal Category: S1A
Further information is available upon request

PP-A1G-IRL-0054 Date of Preparation: September 2024

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
 

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie

 

This website is brought to you by Pfizer Healthcare Ireland Unlimited Company, The Watermarque Building, Ringsend Road, Dublin 4, Dublin, Ireland, D04 K7N3.  Registered in the Republic of Ireland No. 127002. Directors: D. Mangone (Managing), O. Gavan, D. Kennedy. Company Secretary: M.Byrne.  

 

Copyright © 2024 Pfizer Limited. All rights reserved.
 

PP-UNP-IRL-0832. October 2024
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.


PP-UNP-IRL-0832. October 2024
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​
For Healthcare Professionals in the Republic of Ireland *

The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.

I confirm that I am a healthcare professional* resident in the Republic of Ireland.

If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland Unlimited Company.

*The IPHA Code definition of a healthcare professional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses

Terms of use

PP-UNP-IRL-0832. October 2024

Yes No